Hach®, a global leader in water analysis and LuminUltra, a global leader in biological diagnostic testing, have partnered to offer the world’s first rapid, on-site testing solution for the detection of SARS-CoV-2 in wastewater. The partnership is a direct response to consumer and community need for same-day test results and accessible, cost-efficient solutions.
News & Awards
Made-in-Canada: LuminUltra’s rapid, portable qPCR solutions a game-changer for COVID-19 testing at Canada’s largest airport
The Greater Toronto Airport Authority announced that starting March 1 it will use LuminUltra’s game-changing rapid, portable COVID-19 qPCR testing solution on-site at Pearson International Airport, as part of a federally funded research study. The biotechnology front-runner’s GeneCount® COVID-19 RT-qPCR Assay Kit is authorized by Health Canada for sale and distribution.
Universal PropTech Inc. announces agreement with LuminUltra Technologies to provide SARS-CoV-2 (COVID-19) surface testing
Universal PropTech Inc. (TSXV: UPI) is pleased to announce that is has entered into an agreement with LuminUltra Technologies Ltd. to deploy LuminUltra’s GeneCount® Rapid SARS-CoV-2 surface testing solution for UPI’s current customers which total over 2,000 facilities in Canada today.
(Halifax, NS) Researchers across Nova Scotia are launching a project aimed at detecting the presence of the virus that causes COVID-19 in human wastewater, helping to identify the potential presence of the virus quickly and before it can spread. Building on the recent results of a pilot study, the research team has begun to collect… Read More
LuminUltra and BuiltSpace partner with UBC scientists to test cleaning protocols, reducing the risk of COVID-19 spread in indoor educational spaces
Vancouver, B.C. – Dec. 14, 2020 – Biotechnology leader LuminUltra has partnered with BuiltSpace, a building data and asset tracking specialist, and scientists at the University of British Columbia (UBC) to test the effectiveness of disinfection efforts in educational settings for early detection of SARS-CoV-2, the virus that causes COVID-19. “The battle against COVID-19 requires… Read More
Made-in-Canada COVID testing now available: LuminUltra receives Health Canada authorization for rapid, portable COVID-19 qPCR testing solutions
LuminUltra’s point-of-need and high-volume testing solutions capable of serving a range of COVID testing needs in under two hours FREDERICTON, NB, December 3, 2020 – Biotechnology front-runner LuminUltra is pleased to announce that it has received Health Canada authorization to sell and distribute its GeneCount® COVID-19 RT-qPCR Assay Kit. This authorization allows LuminUltra, the Canadian… Read More
LuminUltra expands testing capacity including range of COVID-19 offerings with acquisition of Source Molecular Corporation
FREDERICTON, NB, November 30, 2020 – Biotechnology front-runner LuminUltra today announced the acquisition of Source Molecular Corporation, a leader in lab-based testing solutions for microbial source tracking of pathogens including SARS-CoV-2, the virus that causes COVID-19. With this acquisition, LuminUltra has further expanded its range of molecular testing options for a variety of uses cases…. Read More
LuminUltra partners with The Infection Prevention Strategy to educate on proper COVID-19 disinfection protocol
Partnership brings together leaders in their respective fields to advocate for an innovative, science-based approach to pandemic management CANADA – Nov. 18, 2020 – Biotechnology leader LuminUltra has partnered with The Infection Prevention Strategy (TIPS) in the fight against COVID-19 to provide global education on the importance of verifying proper disinfection protocols with science-based methodology. As a global leader in molecular diagnostic testing, LuminUltra has developed portable qPCR technology that can test for the presence of SARS-CoV-2 –… Read More
A Research Collaboration Between LuminUltra, Dalhousie University and Halifax Water Demonstrates Wastewater Data Is a Powerful Tool in Early Detection and Tracking COVID-19 Prevalence within Communities FREDERICTON, NB, October 21, 2020 – LuminUltra, a Canada-based biotechnology leader and portfolio company of XPV Water Partners, recently filed a patent for the first complete, rapid, and on-site… Read More
The GeneCount® COVID-19 RT-qPCR Assay Kit has been submitted to the U.S. FDA for Emergency Use Authorization and to Health Canada for an Interim Order.